These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12540274)

  • 1. Resistance to anti-peptide deformylase drugs.
    Giglione C; Meinnel T
    Expert Opin Ther Targets; 2001 Jun; 5(3):415-418. PubMed ID: 12540274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide deformylase as an antibacterial drug target: target validation and resistance development.
    Apfel CM; Locher H; Evers S; Takács B; Hubschwerlen C; Pirson W; Page MG; Keck W
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1058-64. PubMed ID: 11257016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial Peptide deformylase inhibitors: a new class of antibacterial agents.
    Jain R; Chen D; White RJ; Patel DV; Yuan Z
    Curr Med Chem; 2005; 12(14):1607-21. PubMed ID: 16022661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide deformylase: a new target in antibacterial, antimalarial and anticancer drug discovery.
    Sangshetti JN; Khan FA; Shinde DB
    Curr Med Chem; 2015; 22(2):214-36. PubMed ID: 25174923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of peptide deformylase inhibitors.
    Chen D; Yuan Z
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1107-16. PubMed ID: 16144495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Discovery of Antibacterial Natural Compound Based on Peptide Deformylase.
    Liang L; Zhou Q; Hao Z; Wang F; Zhu Y; Lin Q; Gao J
    Comb Chem High Throughput Screen; 2018; 21(4):292-297. PubMed ID: 29468960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide deformylase as an antibacterial target: a critical assessment.
    Leeds JA; Dean CR
    Curr Opin Pharmacol; 2006 Oct; 6(5):445-52. PubMed ID: 16904375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand and Structure-Based Approaches for the Identification of Peptide Deformylase Inhibitors as Antibacterial Drugs.
    Gao J; Liang L; Zhu Y; Qiu S; Wang T; Zhang L
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27428963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to antimicrobial therapy: peptide deformylase.
    Waller AS; Clements JM
    Curr Opin Drug Discov Devel; 2002 Sep; 5(5):785-92. PubMed ID: 12630299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actinonin, a naturally occurring antibacterial agent, is a potent deformylase inhibitor.
    Chen DZ; Patel DV; Hackbarth CJ; Wang W; Dreyer G; Young DC; Margolis PS; Wu C; Ni ZJ; Trias J; White RJ; Yuan Z
    Biochemistry; 2000 Feb; 39(6):1256-62. PubMed ID: 10684604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New peptide deformylase inhibitors and cooperative interaction: a combination to improve antibacterial activity.
    Goemaere E; Melet A; Larue V; Lieutaud A; Alves de Sousa R; Chevalier J; Yimga-Djapa L; Giglione C; Huguet F; Alimi M; Meinnel T; Dardel F; Artaud I; Pagès JM
    J Antimicrob Chemother; 2012 Jun; 67(6):1392-400. PubMed ID: 22378679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a human peptide deformylase: implications for antibacterial drug design.
    Nguyen KT; Hu X; Colton C; Chakrabarti R; Zhu MX; Pei D
    Biochemistry; 2003 Aug; 42(33):9952-8. PubMed ID: 12924944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide deformylase: a target for novel antibiotics?
    Pei D
    Expert Opin Ther Targets; 2001 Feb; 5(1):23-40. PubMed ID: 15992166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, antibacterial activity, and biological evaluation of formyl hydroxyamino derivatives as novel potent peptide deformylase inhibitors against drug-resistant bacteria.
    Yang S; Shi W; Xing D; Zhao Z; Lv F; Yang L; Yang Y; Hu W
    Eur J Med Chem; 2014 Oct; 86():133-52. PubMed ID: 25151577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide deformylase inhibitors as potent antimycobacterial agents.
    Teo JW; Thayalan P; Beer D; Yap AS; Nanjundappa M; Ngew X; Duraiswamy J; Liung S; Dartois V; Schreiber M; Hasan S; Cynamon M; Ryder NS; Yang X; Weidmann B; Bracken K; Dick T; Mukherjee K
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3665-73. PubMed ID: 16966397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a new peptide deformylase gene from enterococcus faecium and establishment of a new screening model targeted on PDF for novel antibiotics.
    Tang XB; Si SY; Zhang YQ
    Biomed Environ Sci; 2004 Sep; 17(3):350-8. PubMed ID: 15602833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and refinement of a new structural class of potent peptide deformylase inhibitors.
    Boularot A; Giglione C; Petit S; Duroc Y; Alves de Sousa R; Larue V; Cresteil T; Dardel F; Artaud I; Meinnel T
    J Med Chem; 2007 Jan; 50(1):10-20. PubMed ID: 17201406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae.
    Min S; Ingraham K; Huang J; McCloskey L; Rilling S; Windau A; Pizzollo J; Butler D; Aubart K; Miller LA; Zalacain M; Holmes DJ; O'Dwyer K
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4644-52. PubMed ID: 26014938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrocyclic inhibitors for peptide deformylase: a structure-activity relationship study of the ring size.
    Hu X; Nguyen KT; Jiang VC; Lofland D; Moser HE; Pei D
    J Med Chem; 2004 Sep; 47(20):4941-9. PubMed ID: 15369398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.